On April 15, 2023, Beyond Cells closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,010 KRW | -3.09% | -30.61% | -33.73% |
05-16 | Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-20 | Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-33.73% | 199M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- A092040 Stock
- News Amicogen, Inc.
- Beyond Cells announced that it has received KRW 3 billion in funding from Amicogen, Inc.